Kling-Select is a uniquely promising approach to identifying novel targets and therapeutic antibodies from human and animal sources Kling-Evolve enables highly rapid selection of effective neutralizing antibodies against viral escape variants AMSTERDAM, Oct. 31, 2024 /PRNewswire/ — Kling…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.